Abstract
Summary
LPI (LP Information)' newest research report, the “Drug Discovery Informatics Industry Forecast” looks at past sales and reviews total world Drug Discovery Informatics sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Discovery Informatics sales for 2023 through 2029. With Drug Discovery Informatics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Discovery Informatics industry.
This Insight Report provides a comprehensive analysis of the global Drug Discovery Informatics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Discovery Informatics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Discovery Informatics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Discovery Informatics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Discovery Informatics.
The global Drug Discovery Informatics market size is projected to grow from US$ 1 million in 2022 to US$ 2 million in 2029; it is expected to grow at a CAGR of 9.3% from 2023 to 2029.
United States market for Drug Discovery Informatics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug Discovery Informatics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug Discovery Informatics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug Discovery Informatics players cover IBM, Infosys, Thermo Fisher Scientific, Perkinelmer, Schrödinger, Dassault Systèmes, Charles River Laboratories, Selvita and Certara, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Discovery Informatics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Software
Services
Segmentation by application
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IBM
Infosys
Thermo Fisher Scientific
Perkinelmer
Schrödinger
Dassault Systèmes
Charles River Laboratories
Selvita
Certara
GVK Biosciences
Collaborative Drug Discovery
Openeye Scientific Software
IO Informatics
Novo Informatics
This Insight Report provides a comprehensive analysis of the global Drug Discovery Informatics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Discovery Informatics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Discovery Informatics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Discovery Informatics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Discovery Informatics.
The global Drug Discovery Informatics market size is projected to grow from US$ 1 million in 2022 to US$ 2 million in 2029; it is expected to grow at a CAGR of 9.3% from 2023 to 2029.
United States market for Drug Discovery Informatics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug Discovery Informatics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug Discovery Informatics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug Discovery Informatics players cover IBM, Infosys, Thermo Fisher Scientific, Perkinelmer, Schrödinger, Dassault Systèmes, Charles River Laboratories, Selvita and Certara, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Discovery Informatics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Software
Services
Segmentation by application
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IBM
Infosys
Thermo Fisher Scientific
Perkinelmer
Schrödinger
Dassault Systèmes
Charles River Laboratories
Selvita
Certara
GVK Biosciences
Collaborative Drug Discovery
Openeye Scientific Software
IO Informatics
Novo Informatics
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Discovery Informatics Market Size 2018-2029
2.1.2 Drug Discovery Informatics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Drug Discovery Informatics Segment by Type
2.2.1 Software
2.2.2 Services
2.3 Drug Discovery Informatics Market Size by Type
2.3.1 Drug Discovery Informatics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Drug Discovery Informatics Market Size Market Share by Type (2018-2023)
2.4 Drug Discovery Informatics Segment by Application
2.4.1 Pharmaceutical & Biotechnology Companies
2.4.2 Contract Research Organizations (CROs)
2.4.3 Others
2.5 Drug Discovery Informatics Market Size by Application
2.5.1 Drug Discovery Informatics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Drug Discovery Informatics Market Size Market Share by Application (2018-2023)
3 Drug Discovery Informatics Market Size by Player
3.1 Drug Discovery Informatics Market Size Market Share by Players
3.1.1 Global Drug Discovery Informatics Revenue by Players (2018-2023)
3.1.2 Global Drug Discovery Informatics Revenue Market Share by Players (2018-2023)
3.2 Global Drug Discovery Informatics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Discovery Informatics by Regions
4.1 Drug Discovery Informatics Market Size by Regions (2018-2023)
4.2 Americas Drug Discovery Informatics Market Size Growth (2018-2023)
4.3 APAC Drug Discovery Informatics Market Size Growth (2018-2023)
4.4 Europe Drug Discovery Informatics Market Size Growth (2018-2023)
4.5 Middle East & Africa Drug Discovery Informatics Market Size Growth (2018-2023)
5 Americas
5.1 Americas Drug Discovery Informatics Market Size by Country (2018-2023)
5.2 Americas Drug Discovery Informatics Market Size by Type (2018-2023)
5.3 Americas Drug Discovery Informatics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Discovery Informatics Market Size by Region (2018-2023)
6.2 APAC Drug Discovery Informatics Market Size by Type (2018-2023)
6.3 APAC Drug Discovery Informatics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Discovery Informatics by Country (2018-2023)
7.2 Europe Drug Discovery Informatics Market Size by Type (2018-2023)
7.3 Europe Drug Discovery Informatics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Discovery Informatics by Region (2018-2023)
8.2 Middle East & Africa Drug Discovery Informatics Market Size by Type (2018-2023)
8.3 Middle East & Africa Drug Discovery Informatics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug Discovery Informatics Market Forecast
10.1 Global Drug Discovery Informatics Forecast by Regions (2024-2029)
10.1.1 Global Drug Discovery Informatics Forecast by Regions (2024-2029)
10.1.2 Americas Drug Discovery Informatics Forecast
10.1.3 APAC Drug Discovery Informatics Forecast
10.1.4 Europe Drug Discovery Informatics Forecast
10.1.5 Middle East & Africa Drug Discovery Informatics Forecast
10.2 Americas Drug Discovery Informatics Forecast by Country (2024-2029)
10.2.1 United States Drug Discovery Informatics Market Forecast
10.2.2 Canada Drug Discovery Informatics Market Forecast
10.2.3 Mexico Drug Discovery Informatics Market Forecast
10.2.4 Brazil Drug Discovery Informatics Market Forecast
10.3 APAC Drug Discovery Informatics Forecast by Region (2024-2029)
10.3.1 China Drug Discovery Informatics Market Forecast
10.3.2 Japan Drug Discovery Informatics Market Forecast
10.3.3 Korea Drug Discovery Informatics Market Forecast
10.3.4 Southeast Asia Drug Discovery Informatics Market Forecast
10.3.5 India Drug Discovery Informatics Market Forecast
10.3.6 Australia Drug Discovery Informatics Market Forecast
10.4 Europe Drug Discovery Informatics Forecast by Country (2024-2029)
10.4.1 Germany Drug Discovery Informatics Market Forecast
10.4.2 France Drug Discovery Informatics Market Forecast
10.4.3 UK Drug Discovery Informatics Market Forecast
10.4.4 Italy Drug Discovery Informatics Market Forecast
10.4.5 Russia Drug Discovery Informatics Market Forecast
10.5 Middle East & Africa Drug Discovery Informatics Forecast by Region (2024-2029)
10.5.1 Egypt Drug Discovery Informatics Market Forecast
10.5.2 South Africa Drug Discovery Informatics Market Forecast
10.5.3 Israel Drug Discovery Informatics Market Forecast
10.5.4 Turkey Drug Discovery Informatics Market Forecast
10.5.5 GCC Countries Drug Discovery Informatics Market Forecast
10.6 Global Drug Discovery Informatics Forecast by Type (2024-2029)
10.7 Global Drug Discovery Informatics Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 IBM
11.1.1 IBM Company Information
11.1.2 IBM Drug Discovery Informatics Product Offered
11.1.3 IBM Drug Discovery Informatics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 IBM Main Business Overview
11.1.5 IBM Latest Developments
11.2 Infosys
11.2.1 Infosys Company Information
11.2.2 Infosys Drug Discovery Informatics Product Offered
11.2.3 Infosys Drug Discovery Informatics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Infosys Main Business Overview
11.2.5 Infosys Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Drug Discovery Informatics Product Offered
11.3.3 Thermo Fisher Scientific Drug Discovery Informatics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Perkinelmer
11.4.1 Perkinelmer Company Information
11.4.2 Perkinelmer Drug Discovery Informatics Product Offered
11.4.3 Perkinelmer Drug Discovery Informatics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Perkinelmer Main Business Overview
11.4.5 Perkinelmer Latest Developments
11.5 Schrödinger
11.5.1 Schrödinger Company Information
11.5.2 Schrödinger Drug Discovery Informatics Product Offered
11.5.3 Schrödinger Drug Discovery Informatics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Schrödinger Main Business Overview
11.5.5 Schrödinger Latest Developments
11.6 Dassault Systèmes
11.6.1 Dassault Systèmes Company Information
11.6.2 Dassault Systèmes Drug Discovery Informatics Product Offered
11.6.3 Dassault Systèmes Drug Discovery Informatics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Dassault Systèmes Main Business Overview
11.6.5 Dassault Systèmes Latest Developments
11.7 Charles River Laboratories
11.7.1 Charles River Laboratories Company Information
11.7.2 Charles River Laboratories Drug Discovery Informatics Product Offered
11.7.3 Charles River Laboratories Drug Discovery Informatics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Charles River Laboratories Main Business Overview
11.7.5 Charles River Laboratories Latest Developments
11.8 Selvita
11.8.1 Selvita Company Information
11.8.2 Selvita Drug Discovery Informatics Product Offered
11.8.3 Selvita Drug Discovery Informatics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Selvita Main Business Overview
11.8.5 Selvita Latest Developments
11.9 Certara
11.9.1 Certara Company Information
11.9.2 Certara Drug Discovery Informatics Product Offered
11.9.3 Certara Drug Discovery Informatics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Certara Main Business Overview
11.9.5 Certara Latest Developments
11.10 GVK Biosciences
11.10.1 GVK Biosciences Company Information
11.10.2 GVK Biosciences Drug Discovery Informatics Product Offered
11.10.3 GVK Biosciences Drug Discovery Informatics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 GVK Biosciences Main Business Overview
11.10.5 GVK Biosciences Latest Developments
11.11 Collaborative Drug Discovery
11.11.1 Collaborative Drug Discovery Company Information
11.11.2 Collaborative Drug Discovery Drug Discovery Informatics Product Offered
11.11.3 Collaborative Drug Discovery Drug Discovery Informatics Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Collaborative Drug Discovery Main Business Overview
11.11.5 Collaborative Drug Discovery Latest Developments
11.12 Openeye Scientific Software
11.12.1 Openeye Scientific Software Company Information
11.12.2 Openeye Scientific Software Drug Discovery Informatics Product Offered
11.12.3 Openeye Scientific Software Drug Discovery Informatics Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Openeye Scientific Software Main Business Overview
11.12.5 Openeye Scientific Software Latest Developments
11.13 IO Informatics
11.13.1 IO Informatics Company Information
11.13.2 IO Informatics Drug Discovery Informatics Product Offered
11.13.3 IO Informatics Drug Discovery Informatics Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 IO Informatics Main Business Overview
11.13.5 IO Informatics Latest Developments
11.14 Novo Informatics
11.14.1 Novo Informatics Company Information
11.14.2 Novo Informatics Drug Discovery Informatics Product Offered
11.14.3 Novo Informatics Drug Discovery Informatics Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Novo Informatics Main Business Overview
11.14.5 Novo Informatics Latest Developments
12 Research Findings and Conclusion